KIM-1 as a circulating biomarker in metastatic RCC: Post-hoc analysis of JAVELIN Renal 101.
| Publicado en: | Journal of Clinical Oncology Vol. 43; pp. 594 - 771 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2/10/2025 Supplement5
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184084818&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184084818 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2/10/2025 Supplement5 vid: 43 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 184084818 10.1200/JCO.2025.43.5_suppl.594 184084818 ppf: 594 ppct: 177 formats: tig: atl: KIM-1 as a circulating biomarker in metastatic RCC: Post-hoc analysis of JAVELIN Renal 101. aug: au: Machaalani, Marc Saliby, Renee Maria Zhong, Caiwei Saad, Eddy Steiner, Clara Liu, Xiaowen Cai, Ti Sun, Maxine Lee, Gwo-Shu Mary Xie, Wanling McDermott, David F. Choueiri, Toni K. Xu, Wenxin affil: Dana-Farber Cancer Institute, Boston, MA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|